Dr. Ronghua Jin, Guangxi Medical University, China
Dr. Ronghua Jin is a distinguished researcher in nanomedicine, drug delivery systems, and cancer therapy. He earned his Ph.D. in Chemical Engineering from Xiāan Jiaotong University, focusing on tumor microenvironment-triggered therapeutic platforms. With an M.D. in Physical Chemistry from South China University of Technology and a Bachelorās in Applied Chemistry from Jiujiang University, Dr. Jinās expertise spans theranostics and polymer-based drug delivery. As a Principal Investigator, he has led multiple nationally funded projects, developing targeted nanomedicine strategies for liver cancer treatment. His pioneering work in self-delivery nanomedicine and combined chemotherapy approaches has earned him recognition in the scientific community, making significant contributions to personalized cancer treatment and molecular-targeted therapies.
šĀ Professional Profile:
Orcid
Scopus
š Suitability for the Best Researcher Award
Dr. Ronghua Jinās groundbreaking research in nanomedicine and cancer therapy makes him an outstanding candidate for the Best Researcher Award. His expertise in drug delivery systems and theranostics has led to innovative advancements, including esterase-responsive polymer prodrug delivery and self-delivery nanomedicine. As a Principal Investigator of multiple national and institutional research grants, he has secured significant funding to develop targeted therapies for liver cancer. His work bridges chemistry, nanotechnology, and medicine, enhancing the effectiveness of chemotherapeutic and sonodynamic treatments. With a strong publication record and notable contributions to molecular-targeted cancer therapies, Dr. Jin exemplifies excellence in research, making him highly deserving of this prestigious award.
š EducationĀ
Dr. Ronghua Jin holds a Ph.D. in Chemical Engineering from Xiāan Jiaotong University (2016ā2019), where he developed tumor microenvironment-triggered multimodal therapeutic platforms under the mentorship of Prof. Xin Chen. He earned his M.D. in Physical Chemistry from South China University of Technology (2008ā2011), focusing on ionic liquid-assisted extraction of active pharmaceutical compounds, advised by Prof. Xiaoning An. His academic journey began with a Bachelorās in Applied Chemistry from Jiujiang University (2004ā2008), where he built a strong foundation in chemical applications for medicinal research. His interdisciplinary education has enabled him to integrate chemistry, nanotechnology, and biomedical sciences to develop novel drug delivery and cancer therapy systems.
š¢ Research ExperienceĀ
Dr. Ronghua Jin has extensive research experience in nanomedicine, polymer drug delivery, and cancer therapy. As a Principal Investigator, he has led multiple research projects, including a National Natural Science Foundation of China (NSFC) project (CNY 320,000) on esterase-responsive polymer prodrug delivery for liver cancer therapy. He is also leading a High-Level Talent Project at Guangxi Medical University (CNY 200,000) and a Traditional Chinese Medicine molecular biology research project (CNY 30,000). His work focuses on self-delivery nanomedicine, combining chemotherapy and sonodynamic therapy for targeted liver cancer treatment. His expertise in nanotechnology-driven drug delivery platforms has significantly contributed to advancing personalized medicine and molecular-targeted cancer therapies.
š
Awards and Honors
Dr. Ronghua Jin has received several prestigious research grants and honors for his innovative contributions to nanomedicine and drug delivery systems. He is a Principal Investigator on multiple national and institutional research projects, securing funding from NSFC, Guangxi Medical University, and Traditional Chinese Medicine Treatment Research Programs. His work on esterase-responsive polymer prodrug delivery and self-delivery nanomedicine has been recognized for its breakthrough potential in liver cancer treatment. Dr. Jin has been invited to present his findings at leading international conferences, and his research has been published in top-tier journals. His contributions to theranostics, cancer therapy, and nanomedicine make him a highly respected figure in the field.
š¬ Research FocusĀ
Dr. Ronghua Jinās research specializes in nanomedicine, drug delivery systems, cancer therapy, and theranostics. His work integrates chemistry, biomedical engineering, and nanotechnology to develop targeted therapies for liver cancer. A key focus is on esterase-responsive polymer prodrug delivery, enhancing chemotherapy and sonodynamic treatments. He is also pioneering self-delivery nanomedicine, enabling drugs to actively transport and target cancer cells without external carriers. His research aims to improve the efficiency and precision of drug delivery, reducing side effects and enhancing treatment outcomes. Through his work, he contributes to the advancement of personalized medicine, molecular-targeted therapies, and multi-modal cancer treatment strategies.
š Publication Top Notes:
Antibacterial, Nontoxic, Antifreezing, and Self-Adhesive Conductive Eutectogel for Strain Sensor
Amelioration of Osteoarthritis through Salicylic Acid Nano-Formulated Self-Therapeutic Prodrug
T Cell-Depleting Nanoparticles Ameliorate Bone Loss by Reducing Activated T Cells and Regulating the Treg/Th17 Balance
Multifunctional Hierarchical Nanohybrids Perform Triple Antitumor Theranostics in a Cascaded Manner for Effective Tumor Treatment
2D PtS Nanorectangles/g-CāNā Nanosheets with a Metal SulfideāSupport Interaction Effect for High-Efficiency Photocatalytic Hā Evolution